KBI Biopharma is headed to Sendai for The 3rd Annual Meeting of the Antibody Society of Japan this December!
Schedule a meeting >>
Meet with the KBI Biopharma Team:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
The 3rd Annual Japan Antibody Society Scientific Conference will be held in a hybrid format in Sendai from December 9-11, 2024. This event offers researchers and students in antibody science a platform to present their work through invited lectures, oral presentations, and poster sessions, with awards for outstanding posters. The conference aims to facilitate knowledge exchange and showcase advancements within the antibody research community.